Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the allergic rhinitis market grown over the years?
The market for allergic rhinitis has seen consistent growth in the past few years. The market, which is projected to increase from $15.22 billion in 2024 to $15.74 billion in 2025, is set to grow at a compound annual growth rate (CAGR) of 3.4%. Factors such as increased exposure to allergens, shifts in the environment, heightened public knowledge, escalating pollution levels, advancements in research on allergic rhinitis, and growth in disposable income have contributed to the growth witnessed in the historical period.
What Is the forecasted market size and growth rate for the allergic rhinitis market?
In the near future, the market size for allergic rhinitis is projected to experience steady expansion. The expected growth rate for the market is predicted to be 4.1%, reaching an estimated value of $18.49 billion by 2029. Attributes to this anticipated growth include an increased demand for preventive treatments, an aging population, and urbanization, as well as healthcare spending. Major trends that will mark the forecast period encompass biologics and monoclonal antibodies, the use of digital health solutions, strategies for allergen avoidance, pediatric allergic rhinitis, and technology for allergen detection.
Get your allergic rhinitis market report here!
https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report
What are the major factors driving growth in the allergic rhinitis market?
Rising pollution levels and climate change are expected to fuel the growth of the allergic rhinitis market. Pollution, which involves the presence of harmful substances in the Earth’s atmosphere, along with long-term shifts in climatic patterns known as climate change, can negatively impact human health, the environment, and the quality of the air we breathe. These elements have been identified as major environmental contributors to the increasing incidence and exacerbation of allergic rhinitis, demonstrating a close link between air quality and respiratory health. For instance, the US Environmental Protection Agency reported in August 2024 that around 66 million tons of pollutants were released into the US atmosphere in 2023. Hence, the rise of air pollution and climate change is accelerating the allergic rhinitis market. The growing use of corticosteroid treatment for allergic rhinitis is also likely to steer the market’s growth upwards. The use of medications, known as corticosteroids or steroids, reduces inflammation in nasal passages that can alleviate symptoms related to this condition. For instance, in September 2023, the American Society for Clinical Pharmacology and Therapeutics reported that oral corticosteroids uses averaged at 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark with annual increases ranging from 0.1% to 0.17%. These prescriptions, primarily for short periods (1–29 days), were majorly for healthy adults coping with temporary conditions such as respiratory infections. As such, the increased usage of corticosteroid treatment for allergic rhinitis is contributing to the market growth.
What key areas define the segmentation of the global allergic rhinitis Market?
The allergic rhinitis market covered in this report is segmented –
1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis
2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments
3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count
4) By Route Of Administration: Oral, Nasal, Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores
Subsegments:
1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy
2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy
3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp
What are the top market players propelling the growth of the allergic rhinitis industry?
Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.
What are the key trends shaping the future of the allergic rhinitis market?
Leading businesses in the allergic rhinitis market, such as UK’s Hikma Pharmaceuticals PLC and Switzerland’s Glenmark Specialty S.A., are pushing boundaries with their novel medications to secure their spot in the industry. In a notable development in August 2022, both companies garnered approval for their product, Ryaltris, from the United States Food and Drug Administration (FDA). This landmark product is the first of its kind; a fixed-dose combination medication designed to alleviate nasal and ocular symptoms of seasonal allergic rhinitis in a practical nasal spray format. Suitable for use by adults and children aged 12 and up, patients can anticipate a reduction in nasal symptoms within as little as 15 minutes following the first dose.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12926
What regions are dominating the allergic rhinitis market growth?
North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Allergy Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report
Antibiotic Free Meat Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report
Allergy Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
